BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16773270)

  • 1. Amyotrophic lateral sclerosis: early predictors of prolonged survival.
    Czaplinski A; Yen AA; Appel SH
    J Neurol; 2006 Nov; 253(11):1428-36. PubMed ID: 16773270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictability of disease progression in amyotrophic lateral sclerosis.
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Muscle Nerve; 2006 Dec; 34(6):702-8. PubMed ID: 16967489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?
    Czaplinski A; Yen AA; Simpson EP; Appel SH
    Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of slow and forced vital capacities on ability to predict survival in ALS.
    Pinto S; de Carvalho M
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):528-533. PubMed ID: 28741375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictors of survival in Chinese amyotrophic lateral sclerosis patients.
    Wei Q; Chen X; Zheng Z; Guo X; Huang R; Cao B; Zeng Y; Shang H
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Jun; 16(3-4):237-44. PubMed ID: 25581512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
    Pinto S; Pinto A; de Carvalho M
    Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival in amyotrophic lateral sclerosis: a population-based study.
    Pupillo E; Messina P; Logroscino G; Beghi E;
    Ann Neurol; 2014 Feb; 75(2):287-97. PubMed ID: 24382602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].
    Liu XX; Fan DS; Zhang J; Zhang S; Zheng JY
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2472-5. PubMed ID: 20137433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China.
    Chen L; Zhang B; Chen R; Tang L; Liu R; Yang Y; Yang Y; Liu X; Ye S; Zhan S; Fan D
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1075-81. PubMed ID: 26124198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population.
    Czaplinski A; Yen AA; Appel SH
    J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):390-2. PubMed ID: 16484652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
    Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
    J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis.
    Kanai K; Shibuya K; Sato Y; Misawa S; Nasu S; Sekiguchi Y; Mitsuma S; Isose S; Fujimaki Y; Ohmori S; Koga S; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):734-8. PubMed ID: 22566594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with amyotrophic lateral sclerosis in a population-based registry.
    Millul A; Beghi E; Logroscino G; Micheli A; Vitelli E; Zardi A
    Neuroepidemiology; 2005; 25(3):114-9. PubMed ID: 15956808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
    Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
    Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ALSFRSr predicts survival time in an ALS clinic population.
    Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
    Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALSFRS-R score and its ratio: a useful predictor for ALS-progression.
    Kollewe K; Mauss U; Krampfl K; Petri S; Dengler R; Mohammadi B
    J Neurol Sci; 2008 Dec; 275(1-2):69-73. PubMed ID: 18721928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of slow vital capacity in amyotrophic lateral sclerosis.
    Calvo A; Vasta R; Moglia C; Matteoni E; Canosa A; Mattei A; La Mancusa C; Focaraccio L; Mazzini L; Chiò A; D'Ovidio F; Manera U
    J Neurol; 2020 Jun; 267(6):1615-1621. PubMed ID: 32052165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.
    Desport JC; Marin B; Funalot B; Preux PM; Couratier P
    Amyotroph Lateral Scler; 2008 Oct; 9(5):273-8. PubMed ID: 18720089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosis.
    Capozzo R; Quaranta VN; Pellegrini F; Fontana A; Copetti M; Carratù P; Panza F; Cassano A; Falcone VA; Tortelli R; Cortese R; Simone IL; Resta O; Logroscino G
    J Neurol; 2015 Mar; 262(3):593-603. PubMed ID: 25522696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis.
    Dandaba M; Couratier P; Labrunie A; Nicol M; Hamidou B; Raymondeau M; Logroscino G; Preux PM; Marin B;
    Neuroepidemiology; 2017; 49(1-2):64-73. PubMed ID: 28873374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.